Progranulin (GP88) is an independent prognostic factor for prostate cancer patients

被引：0
|
作者：
Taubert, Helge W. [1 ]
Abdulrahman, Amer [1 ]
Eckstein, Markus [1 ]
Jung, Rudolf [1 ]
Guzman, Juan [1 ]
Weigelt, Katrin [1 ]
Serrero, Ginette [2 ]
Yue, Binbin [2 ]
Geppert, Carol [1 ]
Stoehr, Robert [1 ]
Hartmann, Arndt [1 ]
Wullich, Bernd [1 ]
Wach, Sven [1 ]
机构：
[1] Univ Erlangen Nurnberg, Erlangen, Germany
[2] A&G Pharma, Columbia, MD USA
来源：
CANCER RESEARCH | 2020年 / 80卷 / 16期
关键词：
D O I：
10.1158/1538-7445.AM2020-4327
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4327
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Expression of GP88 (Progranulin) Protein Is an Independent Prognostic Factor in Prostate Cancer Patients
    Abdulrahman, Amer
    Eckstein, Markus
    Jung, Rudolf
    Guzman, Juan
    Weigelt, Katrin
    Serrero, Ginette
    Yue, Binbin
    Geppert, Carol
    Stoehr, Robert
    Hartmann, Arndt
    Wullich, Bernd
    Wach, Sven
    Taubert, Helge
    Lieb, Verena
    CANCERS, 2019, 11 (12)
  • [2] Is the expression of GP88 protein (progranulin) a clinically relevant prognostic factor for prostate cancer patients?
    Taubert H.
    Eckstein M.
    Journal für Urologie und Urogynäkologie/Österreich, 2021, 28 (1): : 21 - 24
  • [3] Expression of GP88 (progranulin) in serum of prostate cancer patients is associated with Gleason scores and overall survival
    Greither, Thomas
    Fischer, Kersten
    Theil, Gerit
    Marcou, Marios
    Holzhausen, Hans-Juergen
    Weigelt, Katrin
    Serrero, Ginette
    Hicks, David
    Yue, Binbin
    Fornara, Paolo
    Wullich, Bernd
    Taubert, Helge
    Wach, Sven
    Lieb, Verena
    CANCER MANAGEMENT AND RESEARCH, 2018, 10 : 4173 - 4180
  • [4] Progranulin (GP88) expression and letrozole resistance in breast cancer
    Serrero, G.
    Dong, J.
    Yue, B.
    Tkaczuk, K. R.
    Chumsri, S.
    Hayashi, J.
    CANCER RESEARCH, 2013, 73
  • [5] Progranulin (GP88) expression in thoracic maligancies
    Serrero, Ginette
    Edelman, Martin J.
    Bejarano, Pablo
    Hawkins, Douglas M.
    Hicks, David
    Reisman, David N.
    Ioffe, Olga
    Feliciano, Josephine
    Yue, Binbin
    CANCER RESEARCH, 2015, 75
  • [6] The Growth Factor GP88 (Progranulin) Confers Aromatase Inhibitor Resistance to Breast Cancer Cells
    Serrero, G.
    Brodie, A.
    Sabnis, G.
    Macedo, L.
    Abrhale, T.
    CANCER RESEARCH, 2009, 69 (24) : 763S - 763S
  • [7] Circulating progranulin (GP88/PGRN) level correlates with survival in metastatic breast cancer patients
    Serrero, Ginette
    Hicks, David
    Yue, Binbin
    Hawkins, Douglas M.
    Tait, Nancy
    Tkaczuk, Katherine H.
    CANCER RESEARCH, 2016, 76
  • [8] Prognostic significance of GP88 for breast cancer recurrence
    Serrero, G.
    Kim, W.
    Yue, B.
    Ioffe, O.
    Barton, R.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [9] Increased Serum GP88 (Progranulin) Concentrations in Rheumatoid Arthritis
    Yamamoto, Yasuko
    Takemura, Masao
    Serrero, Ginette
    Hayashi, Jun
    Yue, Binbin
    Tsuboi, Aya
    Kubo, Hisako
    Mitsuhashi, Takashi
    Mannami, Kenji
    Sato, Masao
    Matsunami, Hidetoshi
    Matuo, Yushi
    Saito, Kuniaki
    INFLAMMATION, 2014, 37 (05) : 1806 - 1813
  • [10] Can GP88 (Progranulin) be Used to Predict the Efficacy of Infliximab?
    Sato, Masao
    Takemura, Masao
    Yamamoto, Yasuko
    Saitozl, Kuniaki
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
12345